Discover 767 paid clinical trials in Elk Grove, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 767
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Location: Sacramento CA, Stanford CA, Redding CA, Los Angeles CA,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT05943535
Phase3, Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Sacramento CA, Carmichael CA, Modesto CA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase3, Recruiting
The Myelin Disorders Biorepository Project
for
Leukodystrophy, White Matter Disease, Leukoencephalopathies,
Location: Sacramento CA, San Francisco CA, Palo Alto CA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT03047369
Recruiting
Transdermal Compress IDE Study
for
Prosthesis and Implants
Location: Sacramento CA, Aurora CO, Chicago IL, Columbus OH,
Sponsor: Balmoral Medical company
Sex: All
Age: 18 - 60
Code: NCT06134167
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Mather CA, Fresno CA, Los Angeles CA, Long Beach CA,
Sponsor: Duke University
Sex: All
Age: 70+
Code: NCT04262206
Recruiting
Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser
for
Immediate Post-Treatment Care, Aging Mid-Face, Aging
Location: Sacramento CA, Nashville TN
Sponsor: Lynch Regenerative Medicine
Sex: All
Age: 40 - 70
Code: NCT07718347
Recruiting
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
for
Congenital Myasthenic Syndrome
Location: Sacramento CA, O'Fallon IL, Chicago IL, Columbus OH,
Sponsor: argenx
Sex: All
Age: 2+
Code: NCT06078553
Recruiting
Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.